A two-year liver health project is underway across the Humber region, aiming to enhance patient care, reduce emergency ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect ...

On Friday, Gilead Sciences, Inc. (NASDAQ:GILD) revealed data from a two-and-a-half-year interim analysis from the ongoing ...

As the prevalence of obesity, alcohol use, and liver disease increases, physicians should take note of patients' lifestyle ...

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...

Consuming alcohol to cope with stress has become more culturally acceptable since 2020, necessitating doctors more ...

We were able to validate these new and exciting observations in patients, providing a route to develop blood biomarkers that ...

We spoke to a a primary care physician for tips on how to prioritize our health as we age — from our 30s through our 70s and ...

Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...